The Effect Of Various Zinc Binding Groups On Inhibition Of Histone Deacetylases 1–11
Andreas S. Madsen, Helle M. E. Kristensen, G. Lanz, C. Olsen
Published 2014 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Histone deacetylases (HDACs) have the ability to cleave the acetyl groups of ε‐N‐acetylated lysine residues in a variety of proteins. Given that human cells contain thousands of different acetylated lysine residues, HDACS may regulate a wide variety of processes including some implicated in conditions such as cancer and neurodegenerative disorders. Herein we report the synthesis and in vitro biochemical profiling of a series of compounds, including known inhibitors as well as novel chemotypes, that incorporate putative new zinc binding domains. By evaluating the compound collection against all 11 recombinant human HDACs, we found that the trifluoromethyl ketone functionality provides potent inhibition of all four subclasses of the Zn2+‐dependent HDACs. Potent inhibition was observed with two different scaffolds, demonstrating the efficiency of the trifluoromethyl ketone moiety as a zinc binding motif. Interestingly, we also identified silanediol as a zinc binding group with potential for future development of non‐hydroxamate class I and class IIb HDAC inhibitors.
This paper references
Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.
T. Suzuki (1999)
HDAC Inhibitors without an Active Site Zn2+-Binding Group
Chris J. Vickers (2012)
A New Synthesis of Ketones Containing One Perfluoroalkyl Group1,2
Kenneth T. Dishart (1956)
Synthesis and Structure of a rac‐Tris(divinyldisiloxane) diplatinum(0) Complex and its Reaction with Maleic Anhydride
P. Hitchcock (1991)
Proteomics 2011, 10, DOI: 10.1074/mcp.M111.012658
a Z. Zhang (2011)
Synthesis and properties of a sterically unencumbered δ-silanediol amino acid.
J. Kim (2012)
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
A. Kazantsev (2008)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
M. Haberland (2009)
Expansion of the lysine acylation landscape.
C. Olsen (2012)
Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.
J. Ontoria (2009)
A structure-based design approach to the development of novel, reversible AChE inhibitors.
C. Doucet-Personeni (2001)
Synthesis of 2-aryl-3,3,3-trifluoropropanoic acids using electrochemical carboxylation of (1-bromo-2,2,2-trifluoroethyl)arenes and its application to the synthesis of β,β,β-trifluorinated non-steroidal anti-inflammatory drugs
Yusuke Yamauchi (2010)
Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.
A. Montero (2009)
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model.
Barbara Attenni (2009)
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
E. Muraglia (2008)
The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells.
J. C. Stowell (1995)
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.
C. Olsen (2009)
Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors
I. Ignatyev (2013)
Zinc binding in HDAC inhibitors: a DFT study.
D. Wang (2007)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
M. Bantscheff (2011)
Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
Kanchan Taori (2008)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.
D. Hutt (2010)
Synthese und Struktur eines rac-Tris(divinyldisiloxan)diplatin(0)-Komplexes und dessen Reaktion mit Maleinsäureanhydrid†
P. Hitchcock (1991)
Trifluoromethyl ketones from enolizable carboxylic acids via enediolate trifluoroacetylation/decarboxylation.
J. T. Reeves (2008)
Steink hler, Bioorg
R. R. Frey (2002)
Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
S. Darkin-Rattray (1996)
Structural biasing elements for in-cell histone deacetylase paralog selectivity.
J. C. Wong (2003)
An epigenetic blockade of cognitive functions in the neurodegenerating brain
J. Gräff (2012)
Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
T. Suzuki (2005)
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
B. Jose (2004)
Sequential C-Si bond formations from diphenylsilane: application to silanediol peptide isostere precursors.
L. Nielsen (2008)
Thiol-based SAHA analogues as potent histone deacetylase inhibitors.
T. Suzuki (2004)
Pd(II)-catalyzed amination of C-H bonds using single-electron or two-electron oxidants.
T. Mei (2009)
.alpha.-Trifluoromethyl-destabilized cations. A route to 1-(trifluoromethyl)tetralins by trifluoroacetolysis of 5-aryl-1,1,1-trifluoropentan-2-ols and derivatives
D. Bonnet-Delpon (1988)
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides.
J. C. Bressi (2010)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
C. Choudhary (2009)
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.
A. Saito (1999)
Synthesis of 5-bromopyridyl-2-magnesium chloride and its application in the synthesis of functionalized pyridines.
J. Song (2004)
A new and efficient synthesis of trifluoromethyl ketones from carboxylic acids. Part I
J. Boivin (1995)
Silandiole: eine neue Klasse potenter Protease‐Inhibitoren
S. M. Sieburth (1998)
Radiosynthesis of 6-([18F]fluoroacetamido)-1-hexanoic-anilide ([18F]FAHA) for PET imaging of histone deacetylase (HDAC)
U. Mukhopadhyay (2006)
Synthesis of fluorinated ketones by means of organolithium compounds and N, N-dialkyl amides of fluorinated acids
N. A. Zaitseva (1961)
FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
R. Furumai (2002)
Signals from NCH 3 , CONCH 3 and CH 2 CONCH 3 were very weak in 13 C NMR, probably due to fast quadrupolar relaxation via the nearby 14 N nuclei
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.
M. Lobera (2013)
Chromatin Modifications and Their Function
T. Kouzarides (2007)
Crystal structure of a bacterial class 2 histone deacetylase homologue.
T. K. Nielsen (2005)
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate.
T. Suzuki (2006)
Investigating the selectivity of metalloenzyme inhibitors.
Joshua A Day (2013)
Anticancer activities of histone deacetylase inhibitors
J. E. Bolden (2006)
Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases.
M. Hirschey (2011)
Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification
M. Tan (2011)
Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.
O. Moradei (2007)
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group.
T. Wu (2004)
Stereocontrolled synthesis of methyl silanediol peptide mimics.
L. Nielsen (2007)
Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
D. M. Fass (2011)
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
F. Wagner (2013)
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
V. Richon (1996)
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
P. Marks (2007)
Inside HDAC with HDAC inhibitors.
P. Bertrand (2010)
Regioselective intramolecular oxidation of phenols and anisoles by dioxiranes generated in situ
Direct conversion of primary and secondary carboxylic acids to trifluoromethyl ketones
J. Reeves (2007)
Syntheses and Facile Cleavage of Five-Membered Ring Sultams1
W. F. Erman (1961)
2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
P. Jones (2008)
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
Ivan V. Gregoretti (2004)
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
S. Kim (2006)
Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials.
L. Snyder (2004)
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates.
T. Suzuki (2003)
Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays.
S. Haggarty (2003)
Sulfamides as novel histone deacetylase inhibitors.
Amal Wahhab (2009)
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
P. Jones (2008)
Hydrated upon standing, giving the hydrate exclusively
Reaction of organometallic reagents with ethyl trifluoroacetate and diethyl oxalate. Formation of trifluoromethyl ketones and .alpha.-keto esters via stable tetrahedral adducts
X. Creary (1987)
Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦
Jessica L Feldman (2013)
A general and versatile synthesis of 2-alkyl-4-aminopyridines
Vidyadhar B. Hegde (2001)
Pyridyl and N,N-dimethylanilyltrifluoromethylketones forming stable gem-diols
R. Salvador (1971)
J. K. Kim
Efficient routes to carbon-silicon bond formation for the synthesis of silicon-containing peptides and azasilaheterocycles.
G. Min (2013)
Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.
Andreas S. Madsen (2012)
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors.
L. A. Marcaurelle (2010)
Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.
J. Villadsen (2013)
α-Keto amides as inhibitors of histone deacetylase
C. Wada (2003)
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.
Chris J. Vickers (2012)
Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine
H. Jiang (2013)
A series of novel, potent, and selective histone deacetylase inhibitors.
P. Jones (2006)
Nickel(0)-katalysierte bildung von carbocyclischen amiden aus α,ω-dienen und phenylisocyanat
E. Hernandez (1987)
Trifluoromethyl ketones as inhibitors of histone deacetylase.
R. Frey (2002)
Histone deacetylase inhibitors: from bench to clinic.
M. Paris (2008)
Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain*
M. Bottomley (2008)
Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases*
C. J. Chou (2008)
Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro.
Andreas S. Madsen (2012)
Inhibition of pheromone action in Sesamia nonagrioides by haloacetate analogues
M. Riba (1994)
Acylierung von Lysinen: Erweiterung des Repertoires
C. Olsen (2012)
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
A. Lahm (2007)
Silanediol Protease Inhibitors: From Conception to Validation†
S. M. Sieburth (2006)
The SiOH-Containing α-Amino Acid HOMe2SiCH2CH(NH2)COOH and Its Immobilization on Silica via an Si−O−Si Linkage
R. Tacke (2005)
Organosilicon molecules with medicinal applications.
A. Franz (2013)
Hydrated upon standing, giving the ketone and hydrate in~1:1 ratio
J. C. Stowell
Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides that Restore Trafficking and Activity of ΔF508-CFTR.
D. Hutt (2011)
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.
M. Ilies (2011)
Microbiological synthesis of variously protected L-glyceraldehydes in high optical purity
G. Guanti (1986)
Identification of lysine succinylation as a new post-translational modification.
Z. Zhang (2011)
Heterologous Reconstitution of the Intact Geodin Gene Cluster in Aspergillus nidulans through a Simple and Versatile PCR Based Approach
M. Nielsen (2013)
Silanediols: A New Class of Potent Protease Inhibitors.
S. Sieburth (1998)
Preparation and utility of dianions from N-tert-butylthiophene-2-sulfonamide
S. Graham (1991)
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
J. Du (2011)
Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists.
J. Regan (2006)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
S. Zhao (2010)
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
Yongcheng Ying (2008)
Chemical Phylogenetics of Histone Deacetylases
J. Bradner (2010)
Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2).
David J Witter (2008)
Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose.
A. Vaidya (2012)
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.
C. Olsen (2012)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S. Minucci (2006)
Determination of pKa values of fluoroalkanesulfonamides and investigation of their nucleophilicity
Cheng-Pan Zhang (2010)
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
Joey L Methot (2008)
K. T. Dishart
This paper is referenced by
Diversity-oriented synthesis of analogues of the novel macrocyclic peptide FR-225497 through late stage functionalization
Jyotiprasad Mukherjee (2015)
Histone Deacetylase Inhibitors: A Prospect in Drug Discovery
Rakesh Yadav (2019)
A Convergent Radical Based Route to Trifluoromethyl Ketones and to α,β-Unsaturated Trifluoromethyl Ketones.
Lucile Anthore (2015)
Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives
Moustafa T Gabr (2017)
A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors.
Yinping Tian (2016)
Clinically Applicable Inhibitors Impacting Genome Stability
Anu Prakash (2018)
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
D. N. Reddy (2016)
Convenient, functional group-tolerant, transition metal-free synthesis of aryl and heteroaryl trifluoromethyl ketones with the use of methyl trifluoroacetate.
Kazumasa Funabiki (2018)
A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.
C. Meyners (2017)
Kinetically selective and potent inhibitors of HDAC8
Markus Schweipert (2019)
Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.
J. Cai (2015)
A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action
Andreas Stahl Madsen (2016)
Preparation and Catalytic Activity of BINOL‐Derived Silanediols
Joshua M. Wieting (2015)
Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase.
Carlos Moreno-Yruela (2018)
Inhibitors of the Zinc‐Dependent Histone Deacetylases
Helle M. E. Kristensen (2019)
Photo-induced coupling reactions of tetrazoles with carboxylic acids in aqueous solution: application in protein labelling.
Shan Zhao (2016)
Application of QM/MM and QM methods to investigate histone deacetylase 8
Duangkamol Gleeson (2015)
Progress in the medicinal chemistry of silicon: C/Si exchange and beyond.
Shinya Fujii (2017)
SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents
Maja Beus (2018)
A practical synthesis of trifluoromethyl alkyl ketones
Dongmei Yang (2015)
Inhibiting Polysulfide Shuttle in Lithium-Sulfur Batteries through Low-Ion-Pairing Salts and a Triflamide Solvent.
A. Shyamsunder (2017)
Assessment of the Allelochemical Activity and Biochemical Profile of Different Phenotypes of Picocyanobacteria from the Genus Synechococcus
Zofia Konarzewska (2020)
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.
Chao-Jun Gong (2016)
Development of a UV-Cleavable Protecting Group for Hydroxylamines, Synthesis of a StructurallyWide Variety of Hydroxamic Acids, and Identification of Histone Deacetylase Inhibitors
Kim T. Mortensen (2017)
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.
R. Ramesh (2018)
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.
L. Musso (2015)
Development and classes of epigenetic drugs for cancer.
D. Dhanak (2014)
Epigenetic drug discovery for Alzheimer’s disease
R. Cacabelos (2014)
Developing drugs targeting transition metal homeostasis.
Claire M Weekley (2017)
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
Qosay A Al-Balas (2016)
Exploring the Influence of the Protein Environment on Metal-Binding Pharmacophores
D. P. Martin (2014)
Chemical Editing of Macrocyclic Natural Products and Kinetic Profiling Reveal Slow, Tight-Binding Histone Deacetylase Inhibitors with Picomolar Affinities.
Betuel Kitir (2017)See more